Open Access Open Access  Restricted Access Subscription or Fee Access

Unani, Phytochemical and Pharmacological Review of Abhal (Juniperus communis) with Special Reference to Female Disorders

Juveriya Naaz N. Bhusnur, Mariyam Roqaiya, Mohammed Asif Siddiqui, Haleema Aneesa K, Shagufta Anwar, Azhar Hasan K, Abdul Ahad, Zeyaul Haque

Abstract


Abstract

Very little research has been commit oneself to and begins to date on relative demand and utilization, or on the extent to which conventional medicines are used as a complement, alternative or supplement to modern medical services. Traditional medicines create an efficient atmosphere in situations associated with chronic conditions. Juniperus communis known as abhal in Unani medicine is one among the thousands of Indian medicinal drugs which is an evergreen tree that grows wild throughout parts of Europe, Asia, and North America. This particular tree grows up to 10 ft tall and has needle-like leaves and seed cones. Unani renowned physicians have described this drug as a potent emmenagogue, so prescribed it for different purposes in females like to treat oligomenorrhoea and amenorrhoea, as an abortifacient and contraceptive drug. Besides, this has also been used to treat other conditions like paralysis, inflammations, infected ulcers, etc. The experimental studies have shown several pharmacological properties. The aim of this review is to explore knowledge about its importance in female diseases and also to update on different aspects of this drug so that further studies can be conducted keeping in view the Unani literature.

 

Keywords: Unani, abhal, phytochemical, pharmacological

Cite this Article

Bhusnur Juveriya Naaz N, Mariyam Roqaiya, Mohammed Asif Siddiqui, et al. Unani, Phytochemical and Pharmacological Review of Abhal (Juniperus communis) with Special Reference to Female Disorders. Research & Reviews: A Journal of Unani, Siddha and Homeopathy. 2018; 5(3): 12–20p


Full Text:

PDF


DOI: https://doi.org/10.37591/rrjoush.v5i3.189

Refbacks

  • There are currently no refbacks.